Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging

Radiology. 1987 Feb;162(2):331-6. doi: 10.1148/radiology.162.2.3797645.


The sensitivity, specificity, accuracy, and positive and negative predictive values of clinical assessment, computed tomography (CT), and magnetic resonance (MR) imaging were compared in the differentiation of stage B from stage C prostatic carcinoma. Forty-six patients who had undergone radical prostatectomy were included in the study. Surgical-pathologic staging was considered the "truth measure." Clinical staging had an accuracy of 61%, and CT, 65%. Accuracy for MR imaging depended on the instrument parameters and plane of section used. When only transverse T1-weighted images were analyzed, MR accuracy was 61%. However, when transverse T1- and T2-weighted images supplemented by additional T2-weighted coronal or sagittal images were studied, accuracy increased to 83%. At present, MR imaging is the most accurate diagnostic modality for the local staging of carcinoma of the prostate, but for optimal results, multiple sequences and two orthogonal planes of imaging are needed.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Humans
  • Lymphatic Metastasis / diagnostic imaging
  • Lymphatic Metastasis / pathology
  • Magnetic Resonance Spectroscopy*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prostate / diagnostic imaging
  • Prostate / pathology
  • Prostatic Neoplasms / diagnostic imaging
  • Prostatic Neoplasms / pathology*
  • Seminal Vesicles / diagnostic imaging
  • Seminal Vesicles / pathology
  • Tomography, X-Ray Computed*